Your session is about to expire
← Back to Search
Analgesic Infusion for Postoperative Pain (ON-Q Trial)
ON-Q Trial Summary
This trial will test if a continuous infusion of local anesthetic or local anesthetic combined with an NSAID can reduce postoperative pain and the amount of narcotics used compared to a control group who only receives saline.
ON-Q Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowON-Q Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.ON-Q Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I can fill out questionnaires by myself.I am scheduled for a robotic or total laparoscopic hysterectomy.I am scheduled for surgery with a specialized surgeon at a study site.I am worried I might have cancer.I am not allergic to Ketorolac or Ropivacaine.I understand the details of the clinical trial and can give my consent.I am planning a hysterectomy for a non-cancerous condition like fibroids or endometriosis.
- Group 1: Normal Saline
- Group 2: Ropivacaine + Ketorolac
- Group 3: Ropivacaine
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- Approved for 5 Other Conditions - This treatment demonstrated efficacy for 5 other conditions.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What other empirical experiments have been performed with regard to Ropivacaine Infusion from ON-Q Pump?
"Currently, there are 101 clinical trials actively researching the efficacy of Ropivacaine Infusion from ON-Q Pump with 22 in Phase 3. These studies can be found at 138 locations around the world, though a majority have their base of operations situated in Boston."
How many participants are signed up for this research study?
"Affirmative. Clinicaltrials.gov documents that recruiting for this medical trial, which was initially posted on September 30th 2019, is currently in progress. The study requires 120 individuals to be enrolled across two distinct sites."
Do I meet the criteria to be a participant in this clinical research?
"To be eligible for this trial, participants must demonstrate postoperative pain and are required to fall within the age range of 18-65. The clinical team is currently recruiting approximately 120 individuals."
How does the ON-Q Pump with Ropivacaine Infusion affect human health?
"The safety rating of Ropivacaine Infusion from ON-Q Pump is 3, as the treatment has already been approved after multiple rounds of trials."
Does this research accept participants aged 55 or older?
"The cutoff for eligible participants in this trial is 65 years of age, with a minimum requirement of 18 years."
What medical maladies can be addressed with Ropivacaine Infusion from ON-Q Pump?
"The preferred method of treating pericarditis acute is Ropivacaine Infusion from ON-Q Pump, as well assisting with ocular itching, pain control and establishing nerve block."
Are there any vacancies for the clinical experiment at this time?
"Affirmative. According to clinicaltrials.gov, this experiment is actively recruiting test subjects; it was first posted on September 30th 2019 and recently updated on October 10 2022. Presently, 120 prospective participants are required from two distinct medical sites."
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger